ISIS Pharmaceuticals (ISIS) Hit Following Two-Notch Analyst Downgrade
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts ISIS Hot Sheet
Join SI Premium – FREE
ISIS Pharmaceuticals (Nasdaq: ISIS) is getting hit Thursday, following a two-notch downgrade at Jefferies, issued earlier.
Shares are over 9 percent lower on the session with volume over 500K shares so far.
Shares are over 9 percent lower on the session with volume over 500K shares so far.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lumentum's optical components sold out through early 2029: CEO
- Seagate Falls 9%, Western Digital Down 6%
- Musk rules out TSMC role in Terafab operations; Intel gains
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
